Omote N, Kanemitsu Y, Inoue T, Yonezawa T, Ichihashi T, Shindo Y, Sakamoto K, Ando A, Suzuki A, Niimi A, Ito S, Imaizumi K, Hashimoto N.
Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19.　 Intern Med. 2022;15;61:233-236.

Mieno Y, Hayashi M, Hirochi M, Ikeda A, Kako H, Ina T, Maeda Y, Maeda S, Inoue T, Souma T, Watanabe T, Horiguchi T, Gotoh Y, Niwa Y, Yamatsuta K, Morikawa S, Sakakibara Y, Okamura T, Uozu S, Goto Y, Isogai S, Fujita S, Fukumoto J, Hosoda N, Imaizumi K.　 Availability of Home sleep apnea test equipment LS-140 on a comparison with Polysomnography.　 Fujita Med J. 2022;8:17-24.

Horiguchi T, Tsukamoto T, Toyama Y, Sasaki T, Nakamura T, Sakurai A, Kiriyama N, Komatsu S, Shigeyasu Y, Ina T, Sakurai E, Nakajima N, Tsuchimori A, Yamada S, Suzuki T, Imaizumi K.
Fatal disseminated mucormycosis associated with COVID-19.
Respirol Case Rep. 2022;13;10:e0912

Fujigaki H, Yamamoto Y, Koseki T, Banno S, Ando T, Ito H, Fujita T, Naruse H, Hata T, Moriyama S, Takahashi Y, Suzuki T, Murakami T, Yoshida Y, Yagura Y, Oyamada T, Takemura M, Kondo M, Iwata M, Saito K.　Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
Microbiol Spectr. 2022;23;10:e0118121.

Tanaka S, Uchino J, Yokoi T, Kijima T, Goto Y, Suga Y, Katayama Y, Nakamura R, Morimoto K, Nakao A, Hibino M, Tani N, Takeda T, Yamaguchi H, Tachibana Y, Takumi C, Hiraoka N, Takeshita M, Onoi K, Chihara Y, Taniguchi R, Yamada T, Matsui Y, Hiranuma O, Morimoto Y, Iwasaku M, Tokuda S, Kaneko Y, Yamada T, Takayama K.　Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer.　Diagnostics (Basel). 2022;6;12:423.

Matsunaga N, Hayakawa K, Asai Y, Tsuzuki S, Terada M, Suzuki S, Ohtsu H, Kitajima K, Toyoda A, Suzuki K, Suzuki M, Saito S, Uemura Y, Shibata T, Kondo M, Nakamura-Uchiyama F, Yokota K, Saito F, Izumi K, Sugiura W, Ohmagari N.
Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study. Lancet Reg Health West Pac. 2022;16;22:100421.

Tsukamoto T, Teramoto A, Yamada A, Kiriyama Y, Sakurai E, Michiba A, Imaizumi K, Fujita H.　Comparison of Fine-Tuned Deep Convolutional Neural Networks for the Automated Classification of Lung Cancer Cytology Images with Integration of Additional Classifiers.　Asian Pac J Cancer Prev. 2022;1;23:1315-1324.

Tsuzuki S, Hayakawa K, Uemura Y, Shinozaki T, Matsunaga N, Terada M, Suzuki S, Asai Y, Kitajima K, Saito S, Yamada G, Shibata T, Kondo M, Izumi K, Hojo M, Mizoue T, Yokota K, Nakamura-Uchiyama F, Saito F, Sugiura W, Ohmagari N. Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan.
Int J Infect Dis. 2022;118:119-125.

Ito M, Shima S, Nagao R, Nakano S, Esaka K, Ueda A, Maeda S, Moriya R, Kondo M, Imaizumi K, Noda S, Katsuno M, Nishino I, Watanabe H.
Nemaline Myopathy Initially Diagnosed as Right Heart Failure with Type 2 Respiratory Failure.　Intern Med. 2022;15;61:1897-1901.

Hiramatsu N, Yamamoto N, Kato Y, Nagai N, Isogai S, Imaizumi K.
Formation of three-dimensional cell aggregates expressing lens-specific proteins in various cultures of human iris-derived tissue cells and iPS cells.
Exp Ther Med. 2022;28;24::539.

Tsuzuki S, Hayakawa K, Doi Y, Shinozaki T, Uemura Y, Matsunaga N, Terada M, Suzuki S, Asai Y, Yamada G, Saito S, Shibata T, Kondo M, Izumi K, Hojo M, Mizoue T, Yokota K, Nakamura-Uchiyama F, Saito F, Sugiura W, Ohmagari N.
Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan.
Infect Dis Ther. 2022;11:1075-1087.

Toda R, Teramoto A, Kondo M, Imaizumi K, Saito K, Fujita H.
Lung cancer CT image generation from a free-form sketch using style-based pix2pix for data augmentation. Sci Rep. 2022;27;12:12867.

Kawachi H, Yamada T, Tamiya M, Negi Y, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Ishida M, Katayama Y, Morimoto K, Iwasaku M, Tokuda S, Kijima T, Takayama K.
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer. JAMA Netw Open. 2023;3;6:e2322915.

Hayashi M, Morikawa S, Goto Y, Yoshida T, Kimura Y, Imaizumi K.
Adverse reactions to mRNA coronavirus disease 2019 (COVID-19) vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 576 medical staff.
Fujita Med J. 2022;8:79-82.

Ohno Y, Aoyagi K, Arakita K, Doi Y, Kondo M, Banno S, Kasahara K, Ogawa T, Kato H, Hase R, Kashizaki F, Nishi K, Kamio T, Mitamura K, Ikeda N, Nakagawa A, Fujisawa Y, Taniguchi A, Ikeda H, Hattori H, Murayama K, Toyama H.
Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect.
Jpn J Radiol. 2022;40:800-813.

Ohno Y, Aoyagi K, Arakita K, Doi Y, Kondo M, Banno S, Kasahara K, Ogawa T, Kato H, Hase R, Kashizaki F, Nishi K, Kamio T, Mitamura K, Ikeda N, Nakagawa A, Fujisawa Y, Taniguchi A, Ikeda H, Hattori H, Murayama K, Toyama H.
Response to RMED-D-22-00,258.R1. Jpn J Radiol. 2022;40:860-861.

Oshita Y, Takeuchi N, Teramoto A, Kondo M, Imaizumi K, Saito K, Fujita H.
[Prognosis Prediction of Lung Cancer Patients Using CT Images: Feature Extraction by Convolutional Neural Network and Prediction by Machine Learning].
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2022;20;78:829-837.

Morimoto K, Sawada R, Yamada T, Azuma K, Ito K, Goto Y, Kimura H, Harada T, Shiotsu S, Tamiya N, Chihara Y, Takeda T, Hiranuma O, Hasegawa I, Morimoto Y, Iwasaku M, Tokuda S, Takayama K.　A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR -Mutant NSCLC. JTO Clin Res Rep. 2022;6;3:100388.

Uda S, Yamada T, Yoshimura A, Goto Y, Yoshimine K, Nakamura Y, Shiotsu S, Yokoi T, Tamiya N, Kimura H, Chihara Y, Umeda Y, Izumi M, Takeda T, Yamada T, Hibino M, Hiranuma O, Ito K, Okada A, Osugi S, Takemura Y, Ishii H, Chibana K, Hasegawa I, Morimoto Y, Iwasaku M, Tokuda S, Takayama K.　Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study. Transl Lung Cancer Res. 2022;11:1847-1857.

Taniguchi Y, Shimokawa T, Takiguchi Y, Misumi T, Nakamura Y, Kawashima Y, Furuya N, Shiraishi Y, Harada T, Tanaka H, Miura S, Uchiyama A, Nakahara Y, Tokito T, Naoki K, Bessho A, Goto Y, Seike M, Okamoto H.
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.　Clin Cancer Res. 2022;14;28:4402-4409.

Tahara A, Hattori H, Matsuyama T, Akamatsu H, Shigeyasu Y, Ina T, Horiguchi T, Imaizumi K, Saito K, Iwata Y, Sugiura K, Tsukamoto T, Toyama H, Ohno Y.
Syphilis With Multiple Pulmonary Nodules and Bone Lesions Detected on Computed Tomography and 18F Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.　J Thorac Imaging. 2022;1;37:W101-W105.

Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I.
Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment.
Clin Lung Cancer. 2022;23:585-592.

Chihara Y, Takeda T, Goto Y, Nakamura Y, Tsuchiya-Kawano Y, Nakao A, Onoi K, Hibino M, Fukuda M, Honda R, Yamada T, Taniguchi R, Sakamoto S, Date K, Nagashima S, Tanzawa S, Minato K, Nakatani K, Izumi M, Shimose T, Kishimoto J, Uchino J, Takayama K.　A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.
Oncologist. 2022;3;27:903-e834.

Hiramatsu N, Yamamoto N, Ohkuma M, Nagai N, Miyachi EI, Yamatsuta K, Imaizumi K.　Iris-derived induced pluripotent stem cells that express GFP in all somatic cells of mice and differentiate into functional retinal neurons.
Med Mol Morphol. 2022;55:292-303.

Teramoto A, Tsukamoto T, Michiba A, Kiriyama Y, Sakurai E, Imaizumi K, Saito K, Fujita H.　Automated Classification of Idiopathic Pulmonary Fibrosis in Pathological Images Using Convolutional Neural Network and Generative Adversarial Networks.
Diagnostics (Basel). 2022;16;12:3195.

Otsubo K, Kishimoto J, Ando M, Kenmotsu H, Minegishi Y, Horinouchi H, Kato T, Ichihara E, Kondo M, Atagi S, Tamiya M, Ikeda S, Harada T, Takemoto S, Hayashi H, Nakatomi K, Kimura Y, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakagawa K, Nakanishi Y, Okamoto I.　Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial.
Eur Respir J. 2022;15;60:2200380.

Sugawara S, Kondo M, Yokoyama T, Kumagai T, Nishio M, Goto K, Nakagawa K, Seto T, Yamamoto N, Kudou K, Asato T, Zhang P, Ohe Y.
Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study
Int J Clin Oncol. 2022;27:1828-1838.

Sugawara S, Kondo M, Yokoyama T, Kumagai T, Nishio M, Goto K, Nakagawa K, Seto T, Yamamoto N, Kudou K, Asato T, Zhang P, Ohe Y.
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study
Int J Clin Oncol. 2022;27:1839-1840.